vs
EOG Resources（EOG）与徕博科（LH）财务数据对比。点击上方公司名可切换其他公司
EOG Resources的季度营收约是徕博科的1.6倍（$5.6B vs $3.5B），EOG Resources净利率更高（12.4% vs 4.7%，领先7.7%），徕博科同比增速更快（5.6% vs 0.9%），过去两年徕博科的营收复合增速更高（5.2% vs -4.0%）
EOG Resources是一家美国能源企业，主营油气勘探开发业务。公司于特拉华州注册，总部设立在得克萨斯州休斯敦的Heritage Plaza大厦，在油气勘探领域拥有成熟的技术储备与运营经验。
徕博科（Labcorp）是全球领先的生命科学与诊断检测企业，面向医疗机构、制药企业和个人患者提供全面的临床检验服务、药物研发支持及医疗检测解决方案，依托先进科研经验与创新技术输出准确可落地的健康洞察，助力临床决策、加快新药研发，提升全球患者健康水平。
EOG vs LH — 直观对比
营收规模更大
EOG
是对方的1.6倍
$3.5B
营收增速更快
LH
高出4.6%
0.9%
净利率更高
EOG
高出7.7%
4.7%
两年增速更快
LH
近两年复合增速
-4.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $5.6B | $3.5B |
| 净利润 | $701.0M | $164.7M |
| 毛利率 | — | 28.2% |
| 营业利润率 | 16.7% | 7.6% |
| 净利率 | 12.4% | 4.7% |
| 营收同比 | 0.9% | 5.6% |
| 净利润同比 | -44.0% | 14.9% |
| 每股收益（稀释后） | $1.31 | $1.98 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EOGLH
| Q4 25 | $5.6B | $3.5B | ||
| Q3 25 | $5.8B | $3.6B | ||
| Q2 25 | $5.5B | $3.5B | ||
| Q1 25 | $5.7B | $3.3B | ||
| Q4 24 | $5.6B | $3.3B | ||
| Q3 24 | $6.0B | $3.3B | ||
| Q2 24 | $6.0B | $3.2B | ||
| Q1 24 | $6.1B | $3.2B |
净利润EOGLH
| Q4 25 | $701.0M | $164.7M | ||
| Q3 25 | $1.5B | $261.1M | ||
| Q2 25 | $1.3B | $237.9M | ||
| Q1 25 | $1.5B | $212.8M | ||
| Q4 24 | $1.3B | $143.4M | ||
| Q3 24 | $1.7B | $169.3M | ||
| Q2 24 | $1.7B | $205.3M | ||
| Q1 24 | $1.8B | $228.0M |
毛利率EOGLH
| Q4 25 | — | 28.2% | ||
| Q3 25 | — | 28.8% | ||
| Q2 25 | — | 29.7% | ||
| Q1 25 | — | 28.3% | ||
| Q4 24 | — | 26.9% | ||
| Q3 24 | — | 27.6% | ||
| Q2 24 | — | 28.8% | ||
| Q1 24 | — | 28.2% |
营业利润率EOGLH
| Q4 25 | 16.7% | 7.6% | ||
| Q3 25 | 31.4% | 11.1% | ||
| Q2 25 | 31.9% | 11.2% | ||
| Q1 25 | 32.8% | 9.7% | ||
| Q4 24 | 28.5% | 6.5% | ||
| Q3 24 | 35.0% | 7.7% | ||
| Q2 24 | 35.4% | 9.2% | ||
| Q1 24 | 37.1% | 10.1% |
净利率EOGLH
| Q4 25 | 12.4% | 4.7% | ||
| Q3 25 | 25.2% | 7.3% | ||
| Q2 25 | 24.6% | 6.7% | ||
| Q1 25 | 25.8% | 6.4% | ||
| Q4 24 | 22.4% | 4.3% | ||
| Q3 24 | 28.0% | 5.2% | ||
| Q2 24 | 28.0% | 6.4% | ||
| Q1 24 | 29.2% | 7.2% |
每股收益（稀释后）EOGLH
| Q4 25 | $1.31 | $1.98 | ||
| Q3 25 | $2.70 | $3.12 | ||
| Q2 25 | $2.46 | $2.84 | ||
| Q1 25 | $2.65 | $2.52 | ||
| Q4 24 | $2.25 | $1.72 | ||
| Q3 24 | $2.95 | $2.00 | ||
| Q2 24 | $2.95 | $2.43 | ||
| Q1 24 | $3.10 | $2.69 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.4B | $532.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $29.8B | $8.6B |
| 总资产 | $51.8B | $18.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资EOGLH
| Q4 25 | $3.4B | $532.3M | ||
| Q3 25 | $3.5B | $598.1M | ||
| Q2 25 | $5.2B | $647.3M | ||
| Q1 25 | $6.6B | $369.4M | ||
| Q4 24 | $7.1B | $1.5B | ||
| Q3 24 | $6.1B | $1.5B | ||
| Q2 24 | $5.4B | $265.1M | ||
| Q1 24 | $5.3B | $99.3M |
股东权益EOGLH
| Q4 25 | $29.8B | $8.6B | ||
| Q3 25 | $30.3B | $8.7B | ||
| Q2 25 | $29.2B | $8.5B | ||
| Q1 25 | $29.5B | $8.3B | ||
| Q4 24 | $29.4B | $8.1B | ||
| Q3 24 | $29.6B | $8.2B | ||
| Q2 24 | $29.2B | $8.0B | ||
| Q1 24 | $28.6B | $8.0B |
总资产EOGLH
| Q4 25 | $51.8B | $18.4B | ||
| Q3 25 | $52.2B | $18.3B | ||
| Q2 25 | $46.3B | $18.1B | ||
| Q1 25 | $47.0B | $17.6B | ||
| Q4 24 | $47.2B | $18.4B | ||
| Q3 24 | $46.2B | $18.6B | ||
| Q2 24 | $45.2B | $16.7B | ||
| Q1 24 | $44.8B | $16.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.6B | $614.2M |
| 自由现金流经营现金流 - 资本支出 | — | $490.3M |
| 自由现金流率自由现金流/营收 | — | 13.9% |
| 资本支出强度资本支出/营收 | — | 3.5% |
| 现金转化率经营现金流/净利润 | 3.73× | 3.73× |
| 过去12个月自由现金流最近4个季度 | — | $1.2B |
8季度趋势，按日历期对齐
经营现金流EOGLH
| Q4 25 | $2.6B | $614.2M | ||
| Q3 25 | $3.1B | $387.2M | ||
| Q2 25 | $2.0B | $620.6M | ||
| Q1 25 | $2.3B | $18.5M | ||
| Q4 24 | $2.8B | $777.2M | ||
| Q3 24 | $3.6B | $277.3M | ||
| Q2 24 | $2.9B | $561.1M | ||
| Q1 24 | $2.9B | $-29.8M |
自由现金流EOGLH
| Q4 25 | — | $490.3M | ||
| Q3 25 | — | $280.5M | ||
| Q2 25 | — | $542.7M | ||
| Q1 25 | — | $-107.5M | ||
| Q4 24 | — | $665.1M | ||
| Q3 24 | — | $161.5M | ||
| Q2 24 | — | $432.9M | ||
| Q1 24 | — | $-163.6M |
自由现金流率EOGLH
| Q4 25 | — | 13.9% | ||
| Q3 25 | — | 7.9% | ||
| Q2 25 | — | 15.4% | ||
| Q1 25 | — | -3.2% | ||
| Q4 24 | — | 20.0% | ||
| Q3 24 | — | 4.9% | ||
| Q2 24 | — | 13.4% | ||
| Q1 24 | — | -5.2% |
资本支出强度EOGLH
| Q4 25 | — | 3.5% | ||
| Q3 25 | — | 3.0% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | 3.8% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | — | 3.5% | ||
| Q2 24 | — | 4.0% | ||
| Q1 24 | — | 4.2% |
现金转化率EOGLH
| Q4 25 | 3.73× | 3.73× | ||
| Q3 25 | 2.11× | 1.48× | ||
| Q2 25 | 1.51× | 2.61× | ||
| Q1 25 | 1.56× | 0.09× | ||
| Q4 24 | 2.21× | 5.42× | ||
| Q3 24 | 2.14× | 1.64× | ||
| Q2 24 | 1.71× | 2.73× | ||
| Q1 24 | 1.62× | -0.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EOG
| Oil And Condensate | $3.0B | 53% |
| Natural Gas Gathering Transportation Marketing And Processing | $1.1B | 20% |
| Natural Gas Production | $847.0M | 15% |
| Natural Gas Liquids Reserves | $666.0M | 12% |
| Other Net | $20.0M | 0% |
LH
| Diagnostics | $2.7B | 78% |
| Biopharma Laboratory Services | $793.0M | 23% |
